
Meta-regression coefficients, by drug class
=========================================================================
                   Outcome               Class  Slope CI.lb CI.ub P-value
-------------------------------------------------------------------------
5            All-cause Mortality        GLP-1RA -0.13 -4.62 4.36   0.96  
1         Cardiovascular Mortality      GLP-1RA -0.78 -5.08 3.51   0.72  
2                   MACE                GLP-1RA -0.97 -5.43 3.49   0.67  
6           Myocardial Infarction       GLP-1RA -1.36 -6.02 3.31   0.57  
7                  Stroke               GLP-1RA 0.78  -3.13 4.68    0.7  
3     Hospitalization for Heart Failure GLP-1RA -1.55 -5.28 2.18   0.42  
4          Composite Renal Outcome      GLP-1RA 0.93  -5.57 7.44   0.78  
12           All-cause Mortality        SGLT2i  -0.38 -0.83 0.07    0.1  
8         Cardiovascular Mortality      SGLT2i  -0.5   -1   0.01   0.05  
9                   MACE                SGLT2i  -1.88 -3.87 0.11   0.06  
13          Myocardial Infarction       SGLT2i  0.15  -2.49 2.78   0.91  
14                 Stroke               SGLT2i  0.08  -2.75 2.91   0.96  
10    Hospitalization for Heart Failure SGLT2i  -1.44 -1.84 -1.05    0   
11         Composite Renal Outcome      SGLT2i  -0.31 -0.97 0.36   0.37  
-------------------------------------------------------------------------
Absolute risk difference and baseline cardiovascular mortality rate      
